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Abstract
Recent genome-wide association studies on several complex diseases have focused on individual
single-nucleotide polymorphism (SNP) analysis; however, not many studies have reported
interactions among genes perhaps because the gene-gene and gene-environment interaction
analysis could be infeasible due to heavy computing requirements. In this study we propose a new
strategy for exploring the interactions among haplotypes. The proposed method consists of two
steps. Step 1 tests the single-SNP association of whole genome with multiple testing corrections
and finds the haplotype blocks of the significant SNPs. Step 2 performs interaction analysis of
haplotypes within blocks. Our proposed method is applied to the rheumatoid arthritis data for
Genetic Analysis Workshop 16.
Background
Complex diseases such as rheumatoid arthritis (RA) are
the results of a complex interplay of genetic and
environmental factors. Previously, a linkage study of
Jawaheer et al. [1] showed that regions from chromo-
some 1 interact with chromosome 6, resulting in
synergistic effect on risk of RA. Simulation studies
showed that interaction analysis can be more powerful
to detect disease associated genes than analysis ignoring
interactions even after correction for multiple testing
[2,3]. Methods based on haplotypes were also shown to
provide additional power for mapping disease genes
when compared with the analysis of individual single-
nucleotide polymorphisms (SNPs) [4,5]. Because a
haplotype comprises multiple SNPs on the same
inherited chromosomes, the haplotype-based
approaches can also provide insight into factors influen-
cing the dependency among genetic markers. Such
insight may provide information essential for under-
standing human evolution and also for identifying cis-
interactions between two or more causal variants [6].
Recently, genome-wide association studies (GWAS) on
several complex diseases were successfully conducted
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genes were reported [7-9]. However, analyses from those
studies only considered individual SNPs, and not many
studies have reported interactions among genes in GWAS
because the gene-gene and gene-environment interaction
analysis could be infeasible due to heavy computing
times. For example, the North American Rheumatoid
Arthritis Consortium (NARAC) data for the genetic data
analysis workshop (GAW16) contains 545,080 SNP-
genotype fields from the Illumina 550 k chip. Note that
more than 10
11 interaction models are possible for all
pairs of SNPs in this data set, which requires enormous
computing times.
In this study, we propose genome-wide analysis of
haplotype interaction (GWAHI) to discover interactions
between unlinked regions based on haplotypes. The
proposed GWAHI consists of the following two steps:
Step 1 tests the single-SNP association of whole genome
with multiple testing corrections and finds the haplotype
blocks of the significant SNPs, and Step 2 performs
interaction analysis of haplotypes within blocks. Our
proposed GWAHI is applied to the RA data for GAW16.
Methods
Data
In the GAW16 RA data, genotypes for 545,080 SNPs
from total 2,062 individuals were provided. The samples
consisted of 868 patients and 1,194 controls. We
excluded outliers of population stratification test per-
formed by Egenstrat [10] and samples showing sex
matching error tested by PLINK [11]. We also excluded
SNPs with minor allele frequency less than 5% or with
the significance level of 10
-6 for Hardy-Weinberg
equilibrium test. After data cleaning, 491,345 SNPs
and 2,048 samples were used in our analysis.
Single-SNP association test
We tested for additive and co-dominant genetic models
using PLINK [11]. For the additive model we used
logistic–genotypic option in PLINK, which provided a
test based on logistic regression; for the co-dominant
model we used model option in PLINK, which provided
a c
2 test. Both tests were performed over the whole
genome. For multiple-testing correction, we applied the
Bonferoni correction. SNPs were selected if they showed
significant association results with p- v a l u e sl e s st h a n
1.03 × 10
7.
Haplotype block construction and association test
We constructed haplotype blocks for each chromosome
using Haploview [12] and Gabriel’s block definition.
Next, we identified haplotype blocks containing one or
more SNPs chosen from the individual SNP test. We also
included haplotype blocks that showed significant
association (p- v a l u e<5 . 3 5×1 0
-7). The haplotype
association test was also performed by PLINK [11]. We
used hap-assoc option in PLINK, which generated
haplotype-specific tests (1 df).
Haplotype interaction
Association tests using haplotype interaction were
conducted using the method introduced by Becker et
al. [3] and implemented in program FAMHAP. FAMHAP
uses the expectation-maximization algorithm to obtain
maximum-likelihood estimates of the haplotype fre-
quencies at each of the unlinked regions for pooled
case-control samples. Then, a contingency table was
constructed that comprises rows referring to disease
status and columns referring to multi-region haplotype
configurations. For association tests, the usual chi-square
tests and permutation tests were performed [3].
Results
Single-SNP and haplotype association analysis
SNP and haplotype association analysis identified 411
significant SNPs and 146 haplotype blocks, among which
255 SNPs and 133 haplotypes were from chromosome 6.
The distribution of the significant SNPs over the chromo-
some is shown in Figure 1. Among 411 SNPs, 219 SNPs
overlapped and were included in the identified haplotype
blocks. In order to see how much influence the significant
SNPs have on the significance of the haplotype blocks, we
calculated the correlation coefficient between the p-values
of overlapped SNPs and haplotype blocks. After the log-
transformation of p-values, the correlation coefficients were
0.7295 (p-value < 1.0 × 10
-15)f o rt h ea d d i t i v em o d e la n d
0.8036 (p-value < 1.0 × 10
-15) for the codominant model.
Thus, we conclude that the significant SNPs have much
influence on the significance of the haplotype blocks. We
also computed the correlation coefficients focusing only on
chromosome 6. For the 211 overlapped SNPs, we obtained
very similar correlation coefficients. When we mapped the
significant SNPs using dbSNP database [13], 238 unique
genes or putative genes were identified. Many SNPs and
blocks were located in the human leukocyte antigen (HLA)
regions, as presented in Table 1. Some of our results
reconfirmed the previous findings on genetic factors
attributable to RA risk reported in the OMIM database
[14]. For example, PTPN22 on chromosome 1, TRAF1 on
chromosome 9, and NFKBIL1, HLA-C,a n dHLA-G on
chromosome 6 were also detected by our association
analysis. Pathway mapping of the 238 identified genes
showed that 51 genes were matched with 60 KEGG
pathways (Additional File 1), among which 18 KEGG
pathways were related to immune responses and
signaling pathways.
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among which 23 SNPs were non-synonymous (Table 2).
We then tested whether the amino-acid substitution
caused by the non-synonymous SNPs affects protein
function damaging using the SIFT program. SIFT predicts
whether an amino acid substitution affects protein
function based on sequence homology and the physical
properties of amino acids [15].
We determined out that two non-synonymous SNPs were
not functionally tolerant and were reported as linked to
disease in OMIM [14]. One of the non-synonymous SNPs
was rs2075800, which was reported to be related with
sarcoidosis [16], an immune system disorder characterized
by non-caseating granulomas [17]. The other SNP was
rs2476601 in PTPN22, which was reported to be associated
with four separate autoimmune phenotypes: type I
diabetes mellitus, RA, systemic lupus erythematosus, and
Hashimoto thyroiditis [18].
Figure 1
The proportion of significant SNPs and haplotype blocks from the single association tests. In our single
association analysis, 62% of the significant SNP and 91% of the significant haplotypes were located in chromosome 6.
There were no significant markers in chromosome 14.
Table 1: The genes containing significant SNPs and haplotype
blocks and comprising the HLA regions
HLA class Locus name No. SNPs No. haplotypes
Class I HLA-C 11
HLA-E 01
HLA-F 01
HLA-G 11
HLA-H 22
HLA-80 11
Class II HLA-DMA 01
HLA-DMB 01
HLA-DOA 12
HLA-DOB 12
HLA-DPA1 41
HLA-DQA1 01
HLA-DQA2 11
HLA-DQB1 10
HLA-DQB2 01
HLA-DRA 01
HLA-DRB9 21
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We started to construct haplotype blocks from the
shortest chromosome 22 sequentially. Due to lack of
memory space in our system (6 GB memory), computa-
tion was completed only for the chromosomes up to 18.
In order to handle memory problem, we split the whole
chromosome into several short regions containing
10,000 SNPs (60 Mb). Each split region was defined to
have 500 overlap SNPs (3 Mb) overlapping with its
neighbor regions. Then we reconstructed the haplotype
blocks for each region and merged them using the
overlapping regions. Through the split-and-merge hap-
lotype reconstruction, a total of 93,397 haplotype blocks
were constructed. The average block length was 17055.5
base-pairs (median, 7638 base-pairs), and one block
included 4.3 SNPs on average (median, 3 SNPs). Finally,
338 haplotype blocks were selected, which contained
either significant SNPs or haplotype blocks.
Haplotype interaction
For Step 2, we conducted the interaction analysis for all
pairs of the 338 haplotype blocks. The interaction analysis
selected 46,995 haplotype pairs from 56,953 possible pairs
(Bonferoni corrected p- v a l u e<8 . 7 8×1 0
-7). Among the
detected haplotype pairs, 13,563 were from chromosome
6; 25,300 pairs included one haplotype from chromosome
6; 8,132 pairs were not from chromosome 6. We then
constructed a haplotype-based network graph in which
each node represents a haplotype. This network graph
illustrates an overview of haplotype interactions. Each edge
represents an interaction of a pair of haplotypes. The more
haplotypes connected, the more interactions exist between
the haplotypes. We identified 39 hub haplotypes that
highly interacted with other haplotypes. Twenty-two of the
hub haplotype were located in 15 gene regions: PSORS1C1,
BAT2, LY6G5C, BAT5, LY6G6D, TNXB, CREBL1, NOTCH4,
LOC401252, C6orf10, BTNL2, HLA-DRA, HLA-DRB9, HLA-
DQA1,a n dTAP2. Most of the hub haplotypes were located
in 6p21.33-6p21.32 (MHC III regions) except one from the
chromosome 7 (rs11762043).
Discussion
RA is an inflammatory disease, primarily of the joints, with
autoimmune features and a complex genetic component.
Among the 411 SNPs we detected from the single-SNP
analysis, only five were previously reported to be associated
with RA. The other 406 SNPs are candidate SNPs associated
with RA. We list the top ten SNPs in the Table 3; the
remaining SNPs are summarized at our website [19]. The
highlighted SNPs were selected by both the additive and
codominant model. Our GWAHI analysis discovered
interactions between haplotype blocks, especially 39 hub
haplotypes included genes expected to be related to
immune response and various signaling pathways. Further
study of these genes may give us more insight into the
mechanism of RA development.
Table 2: The functional class of significant SNPs
Function class No. SNPs
Intron 127
UTR 23
Cds-nonsynonymous 23
Cds-synonymous 7
Locus 32
Table 3: Significant SNPs from the SNP association tests
dbSNP ID Model p-Value Chr Chr position Allele Strand Gene symbol Functional class
rs2395175
a codominant 2.46 × 10
-112 6 32,513,004 A/G +
rs660895 codominant 5.05 × 10
-107 6 32,685,358 A/G +
rs6910071 codominant 6.65 × 10
-94 6 32,390,832 A/G + C6orf10 intron
rs2395163 codominant 1.10 × 10
-90 6 32,495,787 C/T +
rs3763312 codominant 1.87 × 10
-86 6 32,484,326 A/G + BTNL2 locus
rs3763309 codominant 2.06 × 10
-86 6 32,483,951 A/C + BTNL2 locus
rs9275224 codominant 5.96 × 10
-86 6 32,767,856 A/G +
rs6457617 codominant 6.83 × 10
-75 6 32,771,829 C/T +
rs9271568 codominant 1.44 × 10
-66 6 32,698,441 A/G +
rs2395185 codominant 8.68 × 10
-65 6 32,541,145 G/T +
rs660895 additive 1.40 × 10
-62 6 32,685,358 A/G +
rs9271568 additive 5.33 × 10
-56 6 32,698,441 A/G +
rs2395185 additive 3.30 × 10
-55 6 32,541,145 G/T +
rs6910071 additive 7.28 × 10
-55 6 32,390,832 A/G + C6orf10 intron
rs2395163 additive 2.58 × 10
-54 6 32,495,787 C/T +
rs2516049 additive 4.74 × 10
-53 6 32,678,378 A/G -
rs477515 additive 1.25 × 10
-52 6 32,677,669 C/T -
rs3763309 additive 4.34 × 10
-52 6 32,483,951 A/C + BTNL2 locus
rs3763312 additive 5.29 × 10
-51 6 32,484,326 A/G + BTNL2 locus
rs2395175 additive 6.53 × 10
-50 6 32,513,004 A/G +
aBold text indicates that the SNPs are selected by both the additive and codominant model.
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among haplotypes in genome-wide association analysis.
Our proposed GWAHI narrowed down the set of
important haplotype blocks for assessing evidence of
interactions using a two-step analysis. For our haplotype
interaction analysis, we included not only significant
haplotype blocks but also haplotype blocks containing
significantly associated SNPs. This could give us more
insight of the relationships between the significant SNP
and the significant halotypes.
We used the two-step approach to minimize the computa-
tional burden by reducing the number of haplotypes. In
our analysis, the computational time was reasonable
(12 hours using 10 nodes: Dual Core AMD Opteron(TM)
Processor 270 CPU, 6 G memory). However, in this two-
step approach the haplotype interactions without main
effects cannot be detected at Step 1 and thus cannot be
included in interaction analysis at Step 2. If we included
these haplotypes in interaction analysis, then the computa-
tional time would increase exponentially due to the
increase of the number of haplotypes. Thus, it is a
challenge to handle this computational burden more
efficiently for successful GAWHI.
Our haplotype interaction analysis was conducted using
the program FAMHAP. The range of permutation p-values
was dependent on the number of simulations. The p-value
becomes zero when it is below 1.0 × 10
-4 in the default
setting (simulation time, 1 × 10
4). Thus, the rank of the
lowest p-values (p-value = 0) is unattainable. Even though
we increased the simulation time to the 1.0 × 10
8, we still
had the same problem. As the simulation time increased,
the computing time increased exponentially (from 8
second for the default setting to 8 hours for the 1.01.0 ×
10
8 simulation time for one run). In order to get higher
resolution of the corrected p-values, we computed the
p-values of the chi-square statistics from FAMHAP program
by using the chi-square distribution and then applied
Bonferroni correction. In fact, the non-zero permutation
p-values from FAMHAP did not differ much from the
corrected p-values computed by chi-square statistics.
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